The poorly differentiated (mesenchymal-type) MDA-MB-231 cells (denoted MDA-EMT) were obtained from ATCC. OVOL1 and OVOL2 over-expressing (epithelial-type) MDA-MB-231 cells (denoted MDA-Epi) were established as previously described (Roca et al., 2013). Their distinct epithelial and mesenchymal phenotype were confirmed by Western blot for epithelial and mesenchymal marker including E-cadherin, ZEB1, ZEB2, snail and slug (Roca et al., 2013)
Representative traces of PPR in MDA-Epi and MDA-EMT cells. PPR was measured continuously throughout the experimental period at baseline followed by the addition of the indicated drugs. A; oligomycin (1uM), B; 2-DG (100mM). Glycolysis (B), glycolytic capacity (C) and glycolytic reserve (D) were calculated from the mean of three baseline readings. The independent biological experiments were repeated at least three times. Data were represented as the mean ± SD from 8 or 10 Seahorse microplate wells. *P<0.05, **P<0.01. 
